Advanced Enzyme Technologies Ltd.

BSE: 540025 | NSE: ADVENZYMES |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE837H01020 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Advanced Enzym Advanced Enzyme Technologies Ltd. | BSE 328.00 -1.45 (-0.44%) | NSE 328.15 -2.25 (-0.68%) | Trade | Add

BSE Live

Nov 19, 16:01

328.00 -1.45 (-0.44%)

Volume

AVERAGE VOLUME

5-Day

67,083

10-Day

35,989

30-Day

20,893

3,531

Prev. Close

329.45
Open Price

331.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 19, 15:53

328.15 -2.25 (-0.68%)

Volume

AVERAGE VOLUME

5-Day

1,257,683

10-Day

678,093

30-Day

340,474

143,394

Prev. Close

330.40
Open Price

330.40

Bid Price (Qty.)
328.15 (350)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Advanced Enzyme Technologies (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	22.38	22.37	22.37	22.36	22.35
Total Share Capital	22.38	22.37	22.37	22.36	22.35
Reserves and Surplus	1,398.49	1,301.76	1,212.70	1,057.48	945.69
Total Reserves and Surplus	1,398.49	1,301.76	1,212.70	1,057.48	945.69
Total Shareholders Funds	1,420.86	1,324.13	1,235.07	1,088.59	970.66
Minority Interest	47.81	46.95	49.10	51.79	60.11
NON-CURRENT LIABILITIES
Long Term Borrowings	9.18	6.96	7.80	8.13	9.87
Deferred Tax Liabilities [Net]	33.63	34.32	37.23	39.25	39.55
Other Long Term Liabilities	11.73	15.86	14.58	18.35	3.57
Long Term Provisions	1.37	0.89	0.51	1.07	1.36
Total Non-Current Liabilities	55.92	58.03	60.11	66.80	54.35
CURRENT LIABILITIES
Short Term Borrowings	12.35	18.15	5.44	2.81	4.69
Trade Payables	17.20	15.76	24.22	17.90	15.22
Other Current Liabilities	45.83	52.77	44.19	35.89	43.61
Short Term Provisions	21.37	19.68	3.72	3.82	4.04
Total Current Liabilities	96.76	106.36	77.57	60.42	67.56
Total Capital And Liabilities	1,621.35	1,535.46	1,421.85	1,267.61	1,152.67
ASSETS
NON-CURRENT ASSETS
Tangible Assets	292.94	276.53	273.21	262.18	238.20
Intangible Assets	52.29	47.92	54.99	60.87	72.48
Capital Work-In-Progress	21.69	30.74	15.61	9.63	5.04
Fixed Assets	366.94	365.55	349.70	338.11	321.10
Non-Current Investments	0.07	0.17	0.17	0.07	0.07
Deferred Tax Assets [Net]	10.19	14.28	11.34	7.42	6.87
Long Term Loans And Advances	0.07	0.04	0.00	0.00	2.52
Other Non-Current Assets	30.78	20.39	17.68	21.51	15.98
Total Non-Current Assets	741.48	725.72	699.74	663.17	636.61
CURRENT ASSETS
Current Investments	480.26	402.85	359.55	101.95	121.31
Inventories	157.31	148.46	123.99	120.92	93.88
Trade Receivables	115.40	98.57	100.34	88.21	86.27
Cash And Cash Equivalents	107.69	143.50	123.35	273.63	197.77
Short Term Loans And Advances	0.10	0.10	0.12	0.09	0.09
OtherCurrentAssets	19.12	16.27	14.76	19.65	16.73
Total Current Assets	879.87	809.74	722.11	604.44	516.07
Total Assets	1,621.35	1,535.46	1,421.85	1,267.61	1,152.67
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	21.69	20.36	14.12	9.49	18.61
BONUS DETAILS
Bonus Equity Share Capital	15.55	15.55	15.55	15.55	15.55
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.07	0.17	0.17	0.07	0.06
CURRENT INVESTMENTS
Current Investments Quoted Market Value	480.26	57.52	18.17	22.68	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00